Navigation Links
PL Developments To Acquire Aaron Industries
Date:11/18/2013

WESTBURY, N.Y., Nov. 18, 2013 /PRNewswire/ -- PL Developments, Inc., a leader in manufacturing, packaging and distributing solid dose over-the-counter (OTC), private label pharmaceutical and nutritional supplement products, has signed a definitive agreement to acquire Aaron Industries (www.AaronIndustriesInc.com), one of the foremost manufacturers and distributors of liquid dose private label OTC pharmaceutical and consumer health care products for the retail and packaged goods industry. 

The announcement is being made at the Private Label Manufacturers Association (PLMA) 2013 Private Label Trade Show being held at Chicago's Rosemont Convention Center (booth #2511). Terms of the acquisition are not being released as both companies are privately-held. The agreement is subject to government approval under the Hart-Scott-Rodino Act. It is anticipated the deal will close in late November.

The combination of the two companies will create a new force among private label providers to mass merchandisers, drug stores, club stores, dollar stores, grocery chains, convenience stores, drug wholesalers and the entire consumer packaged goods industries. As a result of the acquisition, PL Developments will be an industry leader supplying products to retailers worth more than $1 billion of sales to consumers. With more than 1,000 employees and a manufacturing and distribution footprint across the U.S., PL Developments will feature an impressive and comprehensive array of high quality solid and liquid dose OTC medicines and consumer health care products featuring 300 unique products and 3,000 SKUs.

Aaron Industries, headquartered in Clinton, S.C. and founded in 1981, is a high-quality, low-cost manufacturer of private label and branded liquid pharmaceutical products which include the national brand equivalents of cough, cold, allergy, pain medicines, digestive health items, pediatric electrolytes and first aid items. It has manufacturing facilities in Clinton and in Los Angeles.

"We are very pleased to bring together two well-run organizations with strong cultures that have focused on manufacturing excellence, quality products and high-level customer service," said Mitch Singer, President and CEO, PL Developments. "PL Development's preeminent position in the solid dose market segment, combined with Aaron Industries' strength in liquids and first aid products, allows us to provide greater product depth and choices for the growing needs of our retail partners and the consumer packaged goods industry."

Aaron Industries' operations will be completely integrated into PL Developments with combined company headquarters in Westbury, N.Y.  Its manufacturing and distribution facilities will remain in Clinton and Los Angeles.

"This merger is the culmination of our efforts to build a successful company that produces the highest quality of products by the best people," said James L. Medford, President and CEO, Aaron Industries. "PL Developments is the ideal partner to take us to the next level as the trusted provider to the retail and consumer packaged goods industries. We share the same principles that have driven our individual success which are based on providing value, service, quality, integrity and excellence in all that we do." 

PL Developments and Aaron Industries serve most of the nation's largest retailers including WalMart, Sam's Club, Costco, Walgreen's, CVS, Rite Aid, Kroger, Topco, Target, Dollar General and Family Dollar.

"This is a rare combination of two industry leaders with complementary product lines that fit perfectly together," said Evan Singer, Executive Vice President of Corporate Development, PL Developments. "Both companies have experienced strong growth in recent years and have become important suppliers to our retail and consumer packaged goods customers.  Now, with an expanded array of products and capabilities, we see PL Developments establishing more meaningful relationships with our clients by offering a broader product selection and by utilizing our best in class operations, supply chain and quality systems to provide our clients with a scalable and efficient solution for their store brands.

"PL Developments is well positioned to be part of the solution for reigning in escalating national healthcare costs. We will have an even stronger platform to offer consumers compliant, equivalent and safe OTC alternatives to higher-cost branded and prescription products addressing similar medical needs," said Mr. Singer.

About PL Developments
Founded in 1988 and headquartered in Westbury, N.Y., PL Developments (www.PLDevelopments.com), is a trusted industry partner in the over-the-counter and consumer healthcare industries, serving national retailers and many global consumer product companies. Its mission is to deliver products with the highest level of quality and service at an affordable cost. The company's commitment to quality ensures that every product it produces meets or exceeds industry standards.


'/>"/>
SOURCE PL Developments, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Wireless Health 2013 Convenes Leaders in Health and Sciences to Foster Advanced Developments in Wireless Health
2. Heart Failure Society of America 17th Annual Scientific Meeting To Focus On New Developments In Heart Failure Cause, Care And Treatment
3. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
4. DNA Sequencing 2013 Research Report: Market Developments, Growth Areas and Opportunities
5. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
6. Cardium Presents Year-End 2012 Financial Results And Recent Developments
7. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
8. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
9. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
10. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
11. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... , May 17, 2017  Bayer announced today ... portfolio will be presented at the 53 rd ... (ASCO), taking place June 2-6 in Chicago ... at ASCO span prostate, colorectal, liver and thyroid cancers, ... from the Phase II CHRONOS-1 trial of copanlisib in ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) announced today ... ended April 1, 2017 .   GAAP diluted earnings ... the prior year period as the sale of the ... non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue of ... terms.  Excluding the effects of blood screening and the ...
(Date:5/9/2017)... Ind. , May 9, 2017 Zimmer ... leader in musculoskeletal healthcare, today announced it has earned ... Employers of 2017" list. The Company was ranked among ... of Large Employers and Healthcare Equipment and Services. ... employers based on an anonymous, independent survey of over ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals gained ... was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , ... of independent hearing healthcare providers to help them stay ahead in the industry. At ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to ... campaign in USA Today, which will educate readers on how to take care of ... a large focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs ... on May 30th and 31st at The Four Seasons Hotel Boston. , ... the life sciences, offering exclusive access to key decision makers who influence deal ...
(Date:5/26/2017)... ... ... Amir Qureshi, MD is the first physician in Arkansas to implant Nuvecta’s ... Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for chronic ... introduce the most powerful SCS system and the only stretchable lead on the market. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
Breaking Medicine News(10 mins):